Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichi Kimpara

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Retrovirology|August 24, 2019
Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATLMari Kannagi, Atsuhiko Hasegawa, Yoshiko Nagano, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2018
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphomaLi Lu, Fen Zhu, Meili Zhang, et al.
Molecular Cancer Research : MCR|May 13, 2021
EGR1 Addiction in Diffuse Large B-cell LymphomaShuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Retrovirology|August 24, 2019
Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATLMari Kannagi, Atsuhiko Hasegawa, Yoshiko Nagano, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2018
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphomaLi Lu, Fen Zhu, Meili Zhang, et al.
Molecular Cancer Research : MCR|May 13, 2021
EGR1 Addiction in Diffuse Large B-cell LymphomaShuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Pageof 1